EGFR and neoplasm: This “hijacking” of pro-tumor-immune cells is mediated immunologically by interleukins (IL) such as IL-6 [8], platelet-derived growth factors [9], notch-signaling pathways [10], vascular endothelial growth factor (VEGF) [11], or epidermal growth factor (EGFR) [12].